The Pelotonia Graduate Fellowship Program provides two-year research fellowships to the best and brightest Ohio State University graduate students who want to help cure cancer. Cancer is a complex disease, and curing it will take a multidisciplinary effort. So no matter what their field of study, from traditional scientific fields to fields such as business, history and engineering, all Ohio State graduate students may apply.
Graduate students do a significant amount of work in most labs. Ohio State has many graduate students who are working in the broad field of cancer research, but many of them are not working on independent research projects. Receiving a Pelotonia Graduate Fellowship gives these students the opportunity to fully immerse themselves in the field of cancer research, and to develop and work on their own independent projects.
To date, 128 graduate fellows have been funded (view previous fellows from 2016-2010). These students come from very diverse graduate programs—from Molecular Genetics and Biochemistry to Biomedical Engineering and Psychology—and are working on diverse projects, including development of new bioinformatics algorithms that predict treatment responses for triple negative breast cancer (TNBC), to learning how black raspberries can impact and prevent prostate cancer.
Competition for Pelotonia Graduate Fellowships is fierce. Each year approximately 75 graduate applications are submitted. Each application is critically reviewed by members of the Pelotonia Fellowship Committee. Because of the prestigious nature of these awards, many students have reported that receiving a Pelotonia Fellowship has distinguished them from their peers when going on to do postdoctoral research or moving on to faculty positions.
Graduate Fellows are paid a competitive annual stipend (~$25K), and Ohio State’s Graduate School has generously agreed to pay their fees and tuition.
Applications accepted January 15, 2018 through February 15, 2018
2017 Graduate Student Pelotonia Fellows
Mentor – Jonathon Song
Project – Identifying contributions of pten deleted pancreatic cancer associated fibroblasts to tumor mechanopathology.
Mentor – Andre Palmer
Project – Chemo Sensitization of Triple Negative Breast Cancer Facilitated by Polymerized Human Hemoglobins.
Mentor – Sameek Roychowdhury
Project – Assessment of Microsatellite Instability across the Landscape of Human Cancer.
Mentor – Jonathon Song
Project –Microfluidic lymphatic vessel analogue system for studying lymphangiogenesis and lung cancer intravasation.
Mentor – Michael Caligiuri
Project – Development and Regulation of the Human Group 2 Innate Lymphoid Cell.
Mentor – Michael Freitas
Project – The Tale Behind the Tails: A Mass Spectrometry-Based Approach to Investigate the Role of a Histone Methyltransferase, EZH2, in Chromatin Remodeling, Cell Proliferation and Tumorigenesis.
Mentor – Natarajan Muthusamy and John C Byrd
Project – A Paradigm Shift in Chronic Lymphocytic Leukemia: The Role of Hematopoietic Stem Cells in CLL Leukemogenesis.
Mentor – Yi Zhao
Project – Smartphone Based Whole Slide Scanner for Fast Tumor Identification and Accurate Diagnosis.
Mentor – Marie-Dominique Filippi
Project – Active transforming growth factor ß1 (aTGFß-1) as a predisposing factor of B-acute lymphoblastic leukemia during chronic inflammatory stress.
Mentor – Marcos Sotomayor
Project – Structural insights into protocadherin-7 mediated carcinoma-astrocyte gap junction formation which promotes brain metastasis.
Mentor – Daniel T. Starczynowski
Project – Uncovering mechanisms of del(5q) MDS/AML disease progression through the TIFAB-USP15 signalosome.
Mentor – Zucai Suo
Project – Investigation into the Effects of Human DNA Polymerase ß Cancer Variants on 8-oxoG Repair.
Mentor – Timothy Cripe
Project – The Virus Induced Therapeutic Adjuvant Effect.
Mentor – Barbara Andersen
Project – The Impact of Stress, Depression, and Treatment on Vaccine Responses in Chronic Lymphocytic Leukemia.